Webinars by ProtaGene

Get practical insights into modern bioanalytics and proven methods for biologics as well as cell & gene therapy development. In our live webinars, ProtaGene experts share real-world workflows, common pitfalls, and actionable takeaways — including live Q&A.

Register for our Upcoming Webinar

In this webinar we explore analytical comparability strategies for biologics, covering advanced protein characterization techniques and their role in establishing biosimilarity and product consistency. It highlights how detailed structural and functional analyses enable deeper structure–function understanding to support CMC development, regulatory expectations, and risk-based decision making throughout the biologics lifecycle.

Duration: approx. [45–60] minutes + live Q&A
Format: Live webinar (free)
Language: EN
Speaker: Dr. André Abts (ProtaGene)
Date: September 09ᵗʰ 2026

Who should attend

Scientists in Biologics Development, Analytical Development, CMC, or Biosimilar Development

Missed the live session? Catch up on demand.

Deep-dive talks from leading experts in oncology and proteomics — available anytime.

24. June 2026

HCP Detection Gap Risk Mitigation: Quantitative IAC-MS for ELISA Antibody Reagent Coverage Determination

HCP monitoring relies on ELISA with polyclonal antibodies, whose broad coverage of the actual host cell protein population is critical but difficult to verify. This webinar presents a quantitative IAC-MS approach that determines antibody reagent coverage. It identifies which HCPs the ELISA detects or misses and enables more reliable risk assessment and detection gap mitigation.

Watch Recording

29. April 2026

Beyond Cytotoxicity: A Deep Dive into Effector Function with Advanced Cell‐Based Platforms

Effector functions like CDC, ADCC, and ADCP drive the efficacy of modern biologics, but binding assays alone reveal little about immune activation. Advanced cell-based platforms with reporter cell lines enable precise evaluation of receptor activation and downstream signaling, showing how Fc structure or glycosylation influence therapeutic performance.

Watch Recording

25. February 2026

Host Cell Protein Discovery and Profiling by Mass Spectrometry

Host cell proteins (HCPs) are process-related impurities that can impact product safety, efficacy, and stability. Mass spectrometry enables sensitive and comprehensive identification and characterization of HCPs, supporting effective risk assessment, process optimization, and regulatory compliance.

Watch Recording

Subscribe to Our Email List

Talk to Our Experts

Discover how ProtaGene can support your development programs